Generate a tailored SOP for Dr. Jonathan Danon. Improve your application with a focused, well-structured draft.
Jonathan Danon is a group leader specializing in the synthesis of novel bioactive small molecules at the University of Sydney, with a focus on medicinal chemistry. He received his undergraduate degree (MSci Chemistry Industrial Experience) from the University of Bristol in 2011, during which he spent a year working with AstraZeneca. He was awarded the EaStCHEM Studentship to pursue his PhD in Chemistry, followed by a postdoctoral position with Professor David Leigh at the University of Edinburgh and the University of Manchester from 2011 to 2016. After moving to Australia in 2017, he began an academic career in medicinal chemistry, securing a University of Sydney Postdoctoral Fellowship from 2018 to 2021 to establish an independent research program. In 2022, he commenced an NHMRC research fellowship at the University of Sydney, focusing on developing novel compounds for the treatment of brain disorders. His research interests include Medicinal Chemistry, Organic Synthesis, Chemical Biology, Neuroinflammation, Protein Aggregation, PET Imaging, Atherosclerosis, Supramolecular Chemistry, and Molecular Topology. Jonathan's research aligns with the Faculty of Science's research strengths in Molecules and Materials, as well as Understanding and Treating Diseases.
University of Sydney • Sydney, Australia
Specializes in the synthesis of novel bioactive small molecules.
This entry applies to Faculty of Science PhD programs including Departments such as Life and Environmental Sciences, Physics, Chemistry, and Mathematics and Statistics.